Health care industry

“This medicine could be one of our largest medicines in history,” Novartis CEO Vas Narasimhan told CNBC on…

With open enrollment season in swing, many employees may notice something conspicuously missing from their benefits menu —…

Eli Lilly on Thursday reported third-quarter earnings and revenue that blew past estimates and hiked its full-year sales…

Jim Cramer said Monday that even tech-focused people think the world of Eli Lilly stock, with one predicting…

CNBC is now accepting nominations for the 2027 Changemakers List. Kate Ryder has no doubts about the extent…

UnitedHealth Group signage on the floor of the New York Stock Exchange on April 21, 2025. Michael Nagle…

Johnson & Johnson reported a slightly higher-than-expected profit on Tuesday, driven by strong sales of its immune disease…

People who switched from obesity injections to Novo‘s new Wegovy pill continued to lose weight after three months,…

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…

An Obamacare sign is displayed outside an insurance agency on Nov. 12, 2025, in Miami. Joe Raedle |…

Eli Lilly CEO Dave Ricks told CNBC on Monday that 700,000 new seniors have started GLP-1 treatments since…

Eli Lilly CEO Dave Ricks told CNBC on Monday that one-third of new GLP-1 pill patients are taking…

Novartis remibrutinib MS drug faces efficacy questions